Kanakeswary Karisnan*

Faculty of Medicine, Quest International University, Ipoh Perak, Malaysia

*Corresponding Author: Kanakeswary Karisnan, Faculty of Medicine, Quest International University, Ipoh Perak, Malaysia.

Received: December 30, 2024; Published: January 10, 2025

Abstract

Lung cancer remains one of the leading causes of cancer-related mortality worldwide, with significant gender-specific differences in its incidence, etiology, and outcomes. Among women, lung cancer poses a unique challenge due to differences in hormonal influence, genetic predispositions, and exposure to risk factors such as smoking and environmental carcinogens. In recent years, microRNAs (miRNAs) have emerged as critical regulators of gene expression and promising biomarkers in cancer diagnosis, prognosis, and treatment response. This review explores the roles of miRNA biomarkers in lung cancer, focusing on their implications for women.

References

1. Bartel DP. “MicroRNAs: Genomics, biogenesis, mechanism, and function”. Cell2 (2004): 281-297.
2. Calin G A and Croce C M. “MicroRNA signatures in human cancers”. Nature Reviews Cancer11 (2006): 857-866.
3. Ahn YH and Ko Y H. “Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer”. International Journal of Molecular Sciences22 (2020): 8782.
4. Wu K L., et al. “The Roles of MicroRNA in Lung Cancer”. International Journal of Molecular Sciences7 (2019): 1611.
5. Iorio M V and Croce C M. “MicroRNA dysregulation in cancer: Diagnostics, monitoring, and therapeutics. A Comprehensive Review”. Nature Reviews Genetics12 (2012): 879-889.
6. Esquela-Kerscher A and Slack FJ. “Oncomirs - microRNAs with a role in cancer”. Nature Reviews Cancer4 (2006): 259-269.
7. Miura K., et al. “Distinctive microRNA profiles in lung adenocarcinoma and squamous cell carcinoma”. Molecular and Clinical Oncology 3 (2015): 557-564.
8. Zhang H., et al. “The microRNA network and tumor metastasis”. Oncogene7 (2010): 937-948.
9. Sadeghi MS., et al. “Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review”. Cancer Cell International1 (2023): 284.
10. Hetta HF., et al. “Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer”. MicroRNA (Shariqah, United Arab Emirates)3 (2019): 206-215.
11. Inamura K. “Lung cancer: Understanding its molecular pathology and the 2015 WHO classification”. Frontiers in Oncology 7 (2017): 193.
12. Liang X., et al. “MicroRNAs as early diagnostic biomarkers for non small cell lung cancer (Review)”. Oncology Reports1 (2023): 8.
13. Uddin A and Chakraborty S. “Role of miRNAs in lung cancer”. Journal of Cellular Physiology (2018).

Citation

Citation: Kanakeswary Karisnan. “The Roles of miRNA in Lung Cancer among Women". Acta Scientific Women's Health 7.2 (2025): 10-12.

Copyright

Copyright: © 2025 Kanakeswary Karisnan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.